Glaucoma treatment cost in the Republic of Korea typically ranges from $100 for a detailed ophthalmological investigation to $200 for specialist consultations. Total expenses generally depend on the disease stage and whether laser therapy or surgical intervention is required. Patients can expect approximately 20-40% savings compared to the US, with top-tier care concentrated in Seoul, Incheon, and Busan.
Typical Glaucoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Early-stage patients benefit most from digital monitoring at specialized centers like Seoul National University Bundang Hospital (SNUBH), which utilizes the BESTcare digital system. For complex cases, JCI-accredited Severance Hospital offers advanced ophthalmology departments with high safety standards. Patients seeking expert surgical care can find board-certified specialists at Gangnam Grand Eye Clinic, where doctors have performed over 30,000 procedures.
Bookimed no añade cargos extra a los precios de los tratamientos de Glaucoma. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Glaucoma y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Glaucoma.
Más de 500.000 pacientes tratados con éxito: el Dr. Chong Gi Von es un destacado especialista en cirugías oculares avanzadas en el BGN Eye Hospital.
El Dr. Jinchul Kim es director y oftalmólogo en la Clínica Samsung Miracle Eye, en Gangnam, Seúl. Se especializa en cirugía refractiva, incluidos SMILE y procedimientos con láser, y en cirugía de cataratas y de LIO, con planificación personalizada de lentes. Obtuvo el título de médico en la Facultad de Medicina de la Universidad Nacional de Seúl. Completó la formación como especialista en oftalmología en el Hospital Samsung de Seúl y actualmente es profesor visitante allí. También realizó formación clínica avanzada en la Clínica Mayo, en Estados Unidos.
Entre sus logros figura la “Miracle Formula”, el primer programa del mundo para el cálculo de la potencia de LIO adaptado a perfiles biométricos asiáticos (patente en trámite). Posee la certificación “ZEISS SMILE Excellent Surgeon”. Ha sido invitado como ponente en IOL Power Club 2025 (primer invitado coreano), ASCRS 2025 y ESCRS 2023. Es miembro de KOS, AAO, APAO, ESCRS, ASCRS, APACRS, KEEDS y KCLS.
La Dra. Yoon‑Jung Jo es oftalmóloga certificada y directora de Samsung Miracle Eye Clinic (Gangnam, Seúl). Se licenció en Medicina (MD) y completó la residencia en Oftalmología en Hallym University Medical Center. Posteriormente se desempeñó como profesora visitante y docente clínica. También fue directora de Cheonan Kim Eye Clinic.
Es especialista en cirugía refractiva. Su enfoque incluye SMILE, LASIK y la corrección personalizada 1:1 del astigmatismo y de la visión. La Dra. Jo está certificada como ZEISS SMILE Excellent Surgeon. Es miembro activa de KOS, AAO, APAO, KSCRS, ESCRS, ASCRS, ARVO, KEEDS y KCLS.
El Dr. Seong-Won Cho es director de Oftalmología y especialista en cirugía refractiva en Samsung Miracle Eye Clinic, en Gangnam, Seúl. Cuenta con certificación oficial. Completó el internado y la residencia en oftalmología en el Hospital Anam de la Universidad de Corea. Obtuvo la licenciatura en la Universidad de Boston. Se enfoca en corrección visual avanzada, incluidos los procedimientos SMILE y LASIK. Anteriormente fue director en Blue World Eye Clinic. También fue consultor de oftalmología ambulatoria en el Hospital de la Universidad de Inha.
Acreditaciones: ZEISS SMILE Excellent Surgeon (certificado). Membresías: Korean Medical Association; Korean Ophthalmological Association; Korean Ophthalmological Society; American Academy of Ophthalmology; Asia Pacific Association of Ophthalmologists; Korean External Eye Study Group; Korean Contact Lens Society; Korean Society of Cataract & Refractive Surgery; European Society of Cataract & Refractive Surgeons; American Society of Cataract & Refractive Surgery; ARVO.
South Korean ophthalmologists adapt glaucoma strategies to address specific East Asian genetic traits. Clinicians focus on Normal-Tension Glaucoma, which affects 77% of Korean patients. High rates of myopia and narrow-angle eye structures also require specialized diagnostic software and preventive laser treatments to manage pressure effectively.
Bookimed Expert Insight: Korean specialists have developed proprietary tools like the Miracle Formula at Samsung Miracle Eye Clinic. This world-first IOL power calculation program specifically accounts for Asian biometric profiles. South Korean centers like Asan Medical Center and Severance Hospital manage massive volumes, serving over 10,000 outpatients daily. This experience allows them to refine treatments for high-myopia cases that are often misdiagnosed elsewhere.
Patient Consensus: Patients note that narrow angles are often discovered without symptoms during routine screenings. Many emphasize the importance of immediate preventive laser care once identified to avoid sudden vision loss.
South Korean eye clinics use deep-learning AI screening and micron-level Swept-Source OCT to detect glaucoma and retinal diseases. These facilities integrate digital imaging into unified surgery planning networks. Leading JCI-accredited centers in Seoul employ Pentacam tomography for 3D corneal mapping to ensure high surgical precision.
Bookimed Expert Insight: A major advantage in South Korea is the use of localized diagnostic algorithms. Dr. Jinchul Kim at Samsung Miracle Eye Clinic developed the Miracle Formula. This program is the first IOL power calculation specifically designed for Asian biometric profiles. Choosing a clinic with such specialized tools often leads to more accurate vision correction results.
Minimally Invasive Glaucoma Surgery (MIGS) is widely available in South Korea at specialized ophthalmology centers. JCI-accredited hospitals in Seoul and Incheon utilize microstents and advanced drainage implants. These procedures typically treat mild-to-moderate glaucoma by lowering intraocular pressure with reduced recovery times.
Bookimed Expert Insight: South Korea is uniquely positioned for glaucoma care because of high-volume centers like Severance Hospital. It serves 1.6 million outpatients annually. This massive scale allows surgeons to gain extensive experience with niche MIGS devices faster than in most countries. When choosing a clinic, prioritize those with specialized Ophthalmology and Otolaryngology departments rather than general surgery centers. These dedicated units often house the latest diagnostic equipment like Optical Coherence Tomography (OCT) required for precise MIGS planning.
Patient Consensus: Patients highlight that MIGS is best for those with mild cases looking to reduce daily eye drops. They note that finding a dedicated glaucoma subspecialist in major Seoul hubs is essential for realistic pressure-lowering results.
Selective laser trabeculoplasty (SLT) is a primary alternative to daily glaucoma medication in South Korea. It effectively lowers intraocular pressure by improving fluid drainage. While not a universal replacement, it significantly reduces dependence on eye drops for patients with open-angle glaucoma.
Bookimed Expert Insight: A distinct pattern in South Korean ophthalmology is the focus on biometric customization. Dr. Jinchul Kim at Samsung Miracle Eye Clinic developed a specialized formula for Asian ocular profiles. This level of anatomical precision improves outcomes for laser and lens-based treatments. For patients, this means more accurate pressure control compared to generic protocols.
Patient Consensus: Patients often choose laser therapy to solve the daily struggle of remembering eye drops. Many note that while the laser provides long-term relief, they appreciate having it as a step to delay more invasive surgery.
South Korean ophthalmic centers routinely perform combined cataract and glaucoma surgery in a single session. Surgeons utilize the same incision to remove the cataract and implement glaucoma drainage. This dual approach effectively lowers intraocular pressure while restoring visual clarity during one recovery window.
Bookimed Expert Insight: South Korea is a strategic choice for Asian patients because specialists like Dr. Jinchul Kim at Samsung Miracle Eye Clinic developed the Miracle Formula. This technology optimizes lens power specifically for Asian eye biometric profiles. Choosing a center focused on these regional characteristics can lead to more predictable refractive outcomes after combined surgery.
Patient Consensus: Patients note that combining procedures simplifies travel logistics. Many emphasize clarifying whether the surgery aims to eliminate eye drops or simply manage pressure levels.
South Korean eye clinics are highly specialized in catering to international patients through dedicated global centers. Major facilities in Seoul and Incheon maintain Global Healthcare Accreditation (GHA). They offer English-speaking coordinators and streamlined diagnostic protocols. Most centers provide fully digitalized medical records to ensure seamless follow-up care abroad.
Bookimed Expert Insight: Data shows a clear distinction between boutique refractive clinics and large tertiary hospitals. While private clinics focus on rapid SMILE laser procedures, international patients with complex conditions like glaucoma should choose tertiary centers like Asan Medical Center. These institutions manage over 11,000 outpatients daily and have the infrastructure to handle the long-term medication planning and detailed English reporting required for chronic eye disease management.
Patient Consensus: Patients note that while clinics are extremely efficient, consultations can feel brief and process-driven. It is important to request physical copies of all imaging and a written long-term medication plan before departing Korea.